193 related articles for article (PubMed ID: 27930552)
1. Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis.
Zhang S; Wang Z; Shan J; Yu X; Li L; Lei R; Lin D; Guan S; Wang X
Medicine (Baltimore); 2016 Dec; 95(49):e5546. PubMed ID: 27930552
[TBL] [Abstract][Full Text] [Related]
2. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.
Chen Z; He X; Jia M; Liu Y; Qu D; Wu D; Wu P; Ni C; Zhang Z; Ye J; Xu J; Huang J
PLoS One; 2013; 8(5):e63854. PubMed ID: 23717499
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.
Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336
[TBL] [Abstract][Full Text] [Related]
5. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
[TBL] [Abstract][Full Text] [Related]
6. The relationship between β-catenin and patient survival in colorectal cancer systematic review and meta-analysis.
Matly A; Quinn JA; McMillan DC; Park JH; Edwards J
Crit Rev Oncol Hematol; 2021 Jul; 163():103337. PubMed ID: 33992802
[TBL] [Abstract][Full Text] [Related]
7. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
[No Abstract] [Full Text] [Related]
9. Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival.
Neal CP; Fry AM; Moreman C; McGregor A; Garcea G; Berry DP; Manson MM
J Surg Oncol; 2014 Dec; 110(7):828-38. PubMed ID: 25043295
[TBL] [Abstract][Full Text] [Related]
10. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
He X; Chen Z; Jia M; Zhao X
PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.
Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A
Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469
[TBL] [Abstract][Full Text] [Related]
12. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
[TBL] [Abstract][Full Text] [Related]
13. Association of
Yan H; Jiang F; Yang J
Genet Res (Camb); 2022; 2022():5338956. PubMed ID: 36072013
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of β-catenin expression in patients with ovarian cancer: A meta-analysis.
Long H; Li G; Wen X; Lv Y; Zhang M; Wei Y; Xie W; Zhong P; Pang L
Gene; 2018 Dec; 678():270-279. PubMed ID: 30103006
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
17. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
18. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
19. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis.
Anwar M; Kochhar R; Singh R; Bhatia A; Vaiphei K; Mahmood A; Mahmood S
Mol Carcinog; 2016 Nov; 55(11):1627-1638. PubMed ID: 26373808
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
